Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

被引:27
|
作者
Talaei, Mohammad [1 ]
Faustini, Sian [2 ]
Holt, Hayley [1 ,3 ,4 ]
Jolliffe, David A. [1 ,3 ]
Vivaldi, Giulia [1 ,3 ]
Greenig, Matthew [1 ]
Perdek, Natalia [1 ]
Maltby, Sheena [1 ]
Bigogno, Carola M. [1 ]
Symons, Jane [5 ]
Davies, Gwyneth A. [6 ]
Lyons, Ronan A. [6 ]
Griffiths, Christopher J. [1 ,4 ]
Kee, Frank [7 ]
Sheikh, Aziz [8 ]
Richter, Alex G. [2 ]
Shaheen, Seif O. [1 ]
Martineau, Adrian R. [1 ,3 ,4 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Populat Hlth, London, England
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Queen Mary Univ London, Asthma UK Ctr Appl Res, London, England
[5] Jane Symons Media, London, England
[6] Swansea Univ, Med Sch, Populat Data Sci, Singleton Pk, Swansea, W Glam, Wales
[7] Queens Univ Belfast, Ctr Publ Hlth Res NI, Belfast, Antrim, North Ireland
[8] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
基金
英国科研创新办公室;
关键词
SARS-CoV-2; Serology; Ethnicity; Diet; Micronutrients; Lifestyle; Exercise; Obesity; Alcohol; Occupation; INFECTION;
D O I
10.1186/s12916-022-02286-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a positive swab test result for SARS-CoV-2 prior to enrolment. Information on 88 potential sociodemographic, behavioural, nutritional, clinical and pharmacological risk factors was obtained through online questionnaires, and combined IgG/IgA/IgM responses to SARS-CoV-2 spike glycoprotein were determined in dried blood spots obtained between November 6, 2020, and April 18, 2021. We used logistic and linear regression to estimate adjusted odds ratios (aORs) and adjusted geometric mean ratios (aGMRs) for potential determinants of SARS-CoV-2 seropositivity (all participants) and antibody titres (seropositive participants only), respectively. Results Of 11,130 participants, 1696 (15.2%) were seropositive. Factors independently associated with higher risk of SARS-CoV-2 seropositivity included frontline health/care occupation (aOR 1.86, 95% CI 1.48-2.33), international travel (1.20, 1.07-1.35), number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.29, 1.06-1.57, P-trend = 0.01), body mass index (BMI) >= 25 vs. < 25 kg/m(2) (1.24, 1.11-1.39), South Asian vs. White ethnicity (1.65, 1.10-2.49) and alcohol consumption >= 15 vs. 0 units/week (1.23, 1.04-1.46). Light physical exercise associated with lower risk (0.80, 0.70-0.93, for >= 10 vs. 0-4 h/week). Among seropositive participants, higher titres of anti-Spike antibodies associated with factors including BMI >= 30 vs. < 25 kg/m(2) (aGMR 1.10, 1.02-1.19), South Asian vs. White ethnicity (1.22, 1.04-1.44), frontline health/care occupation (1.24, 95% CI 1.11-1.39), international travel (1.11, 1.05-1.16) and number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.12, 1.02-1.23, P-trend = 0.01); these associations were not substantially attenuated by adjustment for COVID-19 disease severity. Conclusions Higher alcohol consumption and lower light physical exercise represent new modifiable risk factors for SARS-CoV-2 infection. Recognised associations between South Asian ethnic origin and obesity and higher risk of SARS-CoV-2 seropositivity were independent of other sociodemographic, behavioural, nutritional, clinical, and pharmacological factors investigated. Among seropositive participants, higher titres of anti-Spike antibodies in people of South Asian ancestry and in obese people were not explained by greater COVID-19 disease severity in these groups.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
    Mohammad Talaei
    Sian Faustini
    Hayley Holt
    David A. Jolliffe
    Giulia Vivaldi
    Matthew Greenig
    Natalia Perdek
    Sheena Maltby
    Carola M. Bigogno
    Jane Symons
    Gwyneth A. Davies
    Ronan A. Lyons
    Christopher J. Griffiths
    Frank Kee
    Aziz Sheikh
    Alex G. Richter
    Seif O. Shaheen
    Adrian R. Martineau
    BMC Medicine, 20
  • [2] Determinants of pre-vaccination SARS-CoV-2 seropositivity: a population-based longitudinal study (COVIDENCE UK)
    Pashiri, M. Talaei
    Faustini, S.
    Holt, H.
    Jolliffe, D. A.
    Vivaldi, G.
    Richter, A. G.
    Shaheen, S. O.
    Martineau, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
    Jolliffe, David A.
    Faustini, Sian E.
    Holt, Hayley
    Perdek, Natalia
    Maltby, Sheena
    Talaei, Mohammad
    Greenig, Matthew
    Vivaldi, Giulia
    Tydeman, Florence
    Symons, Jane
    Davies, Gwyneth A.
    Lyons, Ronan A.
    Griffiths, Christopher J.
    Kee, Frank
    Sheikh, Aziz
    Shaheen, Seif O.
    Richter, Alex G.
    Martineau, Adrian R.
    VACCINES, 2022, 10 (10)
  • [4] A Population-Based Study of SARS-CoV-2 IgG Antibody Responses to Vaccination in Manitoba
    Martens, Brielle
    Van Caeseele, Paul
    Bullard, Jared
    Loeppky, Carla
    Wei, Yichun
    Reimer, Joss
    Mckinnon, Lyle R.
    Shaw, Souradet Y.
    Kindrachuk, Jason
    Stein, Derek R.
    VACCINES, 2024, 12 (10)
  • [5] Miscarriage after SARS-CoV-2 vaccination: A population-based cohort study
    Velez, Maria P.
    Fell, Deshayne B.
    Shellenberger, Jonas P.
    Kwong, Jeffrey C.
    Ray, Joel G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (04) : 415 - 422
  • [6] Pre-vaccination seroprevalence of SARS-CoV-2 antibodies in the Volta Region, Ghana
    Aninagyei, Enoch
    Ayivor-Djanie, Reuben
    Gyamfi, Jones
    Aboagye, Marfo Edward
    Kpeli, Grace Semabia
    Ampofo, William Kwabena
    Gyapong, John Owusu
    Duedu, Kwabena Obeng
    IJID REGIONS, 2024, 10 : 179 - 182
  • [7] Longitudinal SARS-CoV-2 Antibody Avidity Responses in a SARS-CoV-2 Pregnancy Cohort
    Cassidy, Arianna
    Prahl, Mary
    Song, Dongli
    Jegatheesan, Priya
    Lynch, Kara
    Gaw, Stephanie
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 297 - 298
  • [8] Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study
    Bolijn, Renee
    Spijkerman, Annemieke M. W.
    Galenkamp, Henrike
    Blokstra, Anneke
    Coyer, Liza
    Boyd, Anders
    Prins, Maria
    Stronks, Karien
    PLOS ONE, 2024, 19 (10):
  • [9] SARS-CoV-2 antibodies in research personnel with asymptomatic infection in the pre-vaccination stage
    Solorzano-Santos, Fortino
    Arellano-Galindo, Jose
    Acosta-Contreras, Christian S.
    Klunder-Klunder, Miguel
    de Gante, Carmen L. Perez
    Salazar-Garcia, Marcela
    GACETA MEDICA DE MEXICO, 2023, 159 (04): : 352 - 356
  • [10] A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
    Capoferri, Adam A.
    Shao, Wei
    Spindler, Jon
    Coffin, John M.
    Rausch, Jason W.
    Kearney, Mary F.
    VIRUSES-BASEL, 2022, 14 (01):